MARTIN CADEIRAS
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LOS ANGELES, CA NPI 1013152768
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CA Abbott Laboratories All categories
General Payments — all program years on this page
$5,282.24
- Category: General Payments
- Program years: PY2018–2024
- Record count: 82
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $518.12 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $518.12 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $235.05 | 2 |
| CVRx Inc. | $115.11 | 1 |
| ABIOMED | $48.51 | 1 |
| Lexicon Pharmaceuticals, Inc. | $35.29 | 1 |
| Alnylam Pharmaceuticals Inc. | $22.27 | 1 |
| Acerta Pharma LLC | $22.00 | 1 |
| PFIZER INC. | $21.84 | 1 |
| Recor Medical Inc | $18.05 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081708215 | Lexicon Pharmaceuticals, Inc. | $35.29 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104490012 | AstraZeneca Pharmaceuticals LP | $22.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124792442 | Abbott Laboratories | $19.56 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124792444 | Abbott Laboratories | $215.49 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125831415 | Alnylam Pharmaceuticals Inc. | $22.27 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127686184 | Recor Medical Inc | $18.05 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127781222 | CVRx, Inc. | $115.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131893500 | PFIZER INC. | $21.84 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142247176 | ABIOMED | $48.51 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.